Sort by
Refine Your Search
-
for next generation sequencing, single-cell transcriptomics, flow cytometry, mass spectrometry, metabolomics, bioimaging and transgenic mouse work. Strategic research alliances exist with Odense University
-
of Employment Employment as a PhD fellow is a 3-year salaried position and ends automatically at the conclusion of the period. The position holder may not undertake other paid work during this period. Employment
-
automatically at the end of the period.(the 5+3 programme ). Further information about the PhD programme at the Faculty of Science can be found at the homepage of the University . The University wishes our staff
-
years. Employment stops automatically at the end of the period. The holder of the scholarship is not allowed to have other paid employment during the three-year period (the 5+3 programme ). Further
-
their MSc. Employment stops automatically at the end of the period. · The 4+4 programme: Appointment as a PhD Research Fellow is for four years. It is for students who have not yet completed their masters
-
their MSc. Employment stops automatically at the end of the period. The holder of the scholarship is not allowed to have other paid employment during the three-year period The 4+4 programme : Appointment as a
-
. Application deadline: 20 June 2025 at 23:59 hours local Danish time Application, salary etc. Appointment as a PhD Research Fellow is for three years. Employment stops automatically at the end of the period. The
-
at 23:59 hours local Danish time Application, salary etc. Appointment as a PhD Research Fellow is for three years. Employment stops automatically at the end of the period. The holder of the scholarship is
-
guarantee the EU-funded salary as proposed for the first 18 months - until the end of the project - any continuation beyond this period will follow the rules, regulations, and salary framework applicable
-
academic and social PhD community. The PhD project is part of STEMBRACE an interdisciplinary research project focused on current and future stem cell treatments, addressing ethical, economic, and patient